Latest news
Nelson Dusetti։ Study Explores an AI-Based Histology Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer - OncodailyOncodaily · Sat, 08 Aug 2026 10:07:24 GMTPRODIGE-24/CCTG PA6: Tumor Genomics and Adjuvant Chemotherapy in Resected Pancreatic Cancer - OncodailyOncodaily · Fri, 07 Aug 2026 15:22:17 GMTOne-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer - OncodailyOncodaily · Tue, 04 Aug 2026 15:31:56 GMTctDNA in Gastrointestinal Cancers: What the Evidence Shows - OncodailyOncodaily · Tue, 04 Aug 2026 15:30:14 GMTFeDeriCa: 4-Year Outcomes Support Subcutaneous HER2 Therapy - OncodailyOncodaily · Mon, 03 Aug 2026 18:51:29 GMTAdjuvant Therapy in Renal Cell Carcinoma: Who Benefits and Who Is Overtreated - OncodailyOncodaily · Mon, 03 Aug 2026 13:22:10 GMTShorter Locoregional Radiotherapy Matches Standard Treatment in High-Risk Breast Cancer - OncodailyOncodaily · Fri, 31 Jul 2026 18:46:02 GMTEnfortumab Vedotin–Pembrolizumab Improves Survival in Cisplatin-Eligible Bladder Cancer - OncodailyOncodaily · Fri, 31 Jul 2026 07:00:00 GMT